PURCHASE ORDER
Active75N98026P00992
Department of Health and Human Services › National Institutes of Health › NATIONAL INSTITUTES OF HEALTH OLAO
$147.8K
obligated · signed 3 months ago
NCI - CORRECTIVE EDITING OF SPLICING FACTOR MUTANT MYELODYSPLASTIC SYNDROMES AND CHRONIC MYELOMONOCYTIC LEUKEMIA
Performance timeline
Start
Jul 13, 2026
End
Jul 12, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: Jul 12, 2027
H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC.
Contract 75N98026P00992
UEI
DVHKP4N619V9
Parent Company
H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC.
Capabilities & Certifications
Headquarters Location
Congressional District: 15
Current Obligation
$147,750
Base + Exercised Options
$147,750
Total Ceiling Value
$147,750
Contract Type
FIRM FIXED PRICE
NAICS
TESTING LABORATORIES AND SERVICES
PSC
REFERENCE LABORATORY TESTING
Place of Performance
Congressional District: 08
Awarding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH OLAO
Office
Funding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NIH NCI
Office
Solicitation procedures, competition exceptions, labor standards and account totals.